A Phase I Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Advanced Solid Malignancies

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Veliparib (Primary) ; Carboplatin; Paclitaxel
Indications Adenoid cystic carcinoma; Adrenocortical carcinoma; Advanced breast cancer; Bladder cancer; Carcinoma; Cervical cancer; Cholangiocarcinoma; Chondrosarcoma; Gastric cancer; Head and neck cancer; Malignant melanoma; Neuroblastoma; Non-small cell lung cancer; Oesophageal cancer; Prostate cancer; Small cell lung cancer; Solid tumours; Uterine cancer
Focus Adverse reactions

20 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
07 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
11 Jul 2012 Planned end date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com